Literature DB >> 8623717

Endocarditis in injection drug users.

D E DeWitt1, D S Paauw.   

Abstract

Injection drug use is an important risk factor for endocarditis. The clinical manifestations of endocarditis associated with injection drug use differ from those in person who do not use drugs. Endocarditis in drug users more often affects the right side of the heart and presents with fever and pulmonary emboli rather than left-sided emboli. Blood cultures and echocardiography are the mainstay of diagnosis; these tests are particularly helpful in identification of endocarditis associated with injection drug use because of the high frequency of right-sided valvular involvement and the low incidence of culture-negative endocarditis in this population. Since staphylococcal species are the dominant causative organism, penicillin and an aminoglycoside are the treatments of choice. Injection drug users with left-sided endocarditis or with symptomatic human immunodeficiency virus infection have poor prognoses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623717

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  5 in total

1.  A case of polymicrobial endocarditis caused by anaerobic organisms in an injection drug user.

Authors:  Seunghee Oh; Pamela R Havlen; Nasir Hussain
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

2.  Prevalence and correlates of abscesses among a cohort of injection drug users.

Authors:  Elisa Lloyd-Smith; Thomas Kerr; Robert S Hogg; Kathy Li; Julio S G Montaner; Evan Wood
Journal:  Harm Reduct J       Date:  2005-11-10

3.  Clinical classification and prognosis of isolated right-sided infective endocarditis.

Authors:  Carlos Ortiz; Javier López; Héctor García; Teresa Sevilla; Ana Revilla; Isidre Vilacosta; Cristina Sarriá; Carmen Olmos; Carlos Ferrera; Pablo Elpidio García; Carmen Sáez; Itziar Gómez; José Alberto San Román
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

4.  Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City.

Authors:  Sanjana Mitra; Beth Rachlis; Ayden Scheim; Geoff Bardwell; Sean B Rourke; Thomas Kerr
Journal:  Harm Reduct J       Date:  2017-07-14

5.  Potential use of supervised injection services among people who inject drugs in a remote and mid-size Canadian setting.

Authors:  Sanjana Mitra; Beth Rachlis; Bonnie Krysowaty; Zack Marshall; Cynthia Olsen; Sean Rourke; Thomas Kerr
Journal:  BMC Public Health       Date:  2019-03-08       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.